Cronos (CRON) Restructuring Costs (2023 - 2026)

Cronos (CRON) recorded quarterly Restructuring Costs of $484000.0 in Q1 2026, down 3.59% quarter-over-quarter from $502000.0 in Q4 2025, and down 12.79% on a YoY basis from $555000.0 in Q1 2025.

Cronos (CRON) Restructuring Costs (2023 - 2026) Analysis & Trends

Cronos' Restructuring Costs history runs 4 years deep, the most recent figure standing at $484000.0 for Q1 2026.

  • In Q1 2026, Restructuring Costs fell 12.79% year-over-year to $484000.0; the TTM figure through Mar 2026 stood at $2.0 million (up 78.4% YoY), while the FY2025 annual figure was $2.0 million, up 223.33% from the prior year.
  • Restructuring Costs was $484000.0 for Q1 2026 at Cronos, down from $502000.0 in the prior quarter.
  • In the past five years, Restructuring Costs ranged from a high of $1.4 million in Q3 2023 to a low of $83000.0 in Q1 2024.
  • Historically, Restructuring Costs has averaged $519444.4 across 4 years, with a median of $502000.0 in 2025.
  • The sharpest annual moves came in 2025 and 2026: Restructuring Costs jumped 568.67% in 2025, then fell 12.79% in 2026.
  • A 4-year view of Restructuring Costs shows it stood at $101000.0 in 2023, then surged by 441.58% to $547000.0 in 2024, then declined by 8.23% to $502000.0 in 2025, then fell by 3.59% to $484000.0 in 2026.
  • The last three Restructuring Costs figures came in at $484000.0 (Q1 2026), $502000.0 (Q4 2025), and $212000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Cronos 1.06 Bn 292.44 Mn 19.15 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 484,000.00
Dec 31, 2025 502,000.00
Sep 30, 2025 212,000.00
Jun 30, 2025 768,000.00
Mar 31, 2025 555,000.00
Jun 30, 2024 547,000.00
Mar 31, 2024 83,000.00
Dec 31, 2023 101,000.00
Sep 30, 2023 1.42 Mn